Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000945621-25-000820
Filing Date
2025-08-27
Accepted
2025-08-27 16:24:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5324
  Complete submission text file 0000945621-25-000820.txt   6998
Mailing Address 7118 MELROSE CASTLE LANE BOCA RATON FL 33496
Business Address
COOPERMAN LEON G (Filed by) CIK: 0000898382 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 0000

Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90788 | Film No.: 251265559
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)